ADVFN - Advanced Financial Network.
HOME» NYSE » M » MDT Stock Price » MDT Stock News

Medtronic Share News

 Medtronic, Inc. Stock Price
MDT Stock Price
 Medtronic, Inc. Stock Chart
MDT Stock Chart
 Medtronic, Inc. Stock News
MDT Stock News
 Medtronic, Inc. Company Information
MDT Company Information
 Medtronic, Inc. Stock Trades
MDT Stock Trades

Medtronic Unveils Details Of $1.08 Billion Debt Sale

DOW JONES NEWSWIRES Medtronic Inc. (MDT) unveiled details of its sale of nearly $1.08 billion of debt in two series of senior notes as the medical-devices maker raises funds for working capital and other purposes, which may include debt repayments. Medtronic sold $675 million of 10-year notes priced to yield 3.161%, or 0.90 percentage points over Treasurys, and $400 million of 30-year notes priced to yield 4.51%, or 1.1 points over Treasurys. The pricing of each bond was 0.05 points tighter than earlier guidance, indicating broad demand. Medtronic's debt sale is one of at least four sizable issues in the U.S. bond market Wednesday amid signs that investor demand for risky assets is holding up, particularly after the Federal Reserve indicated Tuesday most of the biggest U.S. banks passed the latest round of stress tests. The company, which has continued to see challenges in its key cardiac rhythm and spine business, last month reported that its fiscal third-quarter earnings rose 1.2% thanks to fewer charges and the impact of shedding its Physio-Control business. Shares were down 10 cents at $38.56 in recent trading. -By Tess Stynes, Dow Jones Newswires; 212-416-2481; [email protected]

Stock News for Medtronic (MDT)
DateTimeHeadline
03/24/201709:00:43New Guidelines Support Use of Cardiac Monitoring for Patients...
03/23/201709:15:52Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
03/23/201709:15:52Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
03/23/201706:04:44Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
03/23/201706:04:44Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
03/22/201717:47:00Medtronic Files 8K - Other Events
03/22/201717:18:26Current Report Filing (8-k)
03/22/201715:50:01Amended Statement of Changes in Beneficial Ownership (4/a)
03/22/201709:00:48Medtronic Receives FDA Approval for CoreValve(TM) Evolut(TM...
03/22/201708:30:00Big Data Poses Big Headaches as Health Care Industry Adopts HIT...
03/22/201706:05:07Free Writing Prospectus - Filing Under Securities Act Rules 163/433...
03/22/201706:05:07Free Writing Prospectus - Filing Under Securities Act Rules 163/433...
03/22/201706:05:07Free Writing Prospectus - Filing Under Securities Act Rules 163/433...
03/22/201706:04:18Free Writing Prospectus - Filing Under Securities Act Rules 163/433...
03/21/201720:00:22Medtronic Announces Pricing of $2 Billion of Senior Notes
03/21/201718:08:55Statement of Changes in Beneficial Ownership (4)
03/21/201708:44:37Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)
03/21/201708:44:37Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)
03/21/201708:42:28Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)
03/21/201708:42:28Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Medtronic and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US